Sumerauer, D., Krskova, L., Kyncl, M., Zapotocky, M., Kuklova, A., Zamecnik, J., . . . Stary, J. (2018). LGG-31. SUSTAINED OBJECTIVE RESPONSE TO DABRAFENIB THERAPY ACROSS DIFFERENT BRAIN HISTOLOGIES HARBOURING BRAF V600E ACTIVATING MUTATION. Neuro Oncol.
Citação norma ChicagoSumerauer, David, Lenka Krskova, Martin Kyncl, Michal Zapotocky, Adela Kuklova, Josef Zamecnik, Barbora Ondrova, and Jan Stary. "LGG-31. SUSTAINED OBJECTIVE RESPONSE TO DABRAFENIB THERAPY ACROSS DIFFERENT BRAIN HISTOLOGIES HARBOURING BRAF V600E ACTIVATING MUTATION." Neuro Oncol 2018.
Citação norma MLASumerauer, David, et al. "LGG-31. SUSTAINED OBJECTIVE RESPONSE TO DABRAFENIB THERAPY ACROSS DIFFERENT BRAIN HISTOLOGIES HARBOURING BRAF V600E ACTIVATING MUTATION." Neuro Oncol 2018.